These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31154042)

  • 1. Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease.
    Caverly LJ; Huang YJ; Sze MA
    Chest; 2019 Aug; 156(2):376-382. PubMed ID: 31154042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases.
    Magryś A
    Pol J Microbiol; 2021 Mar; 70(1):25-32. PubMed ID: 33815524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology.
    Larsen JM; Musavian HS; Butt TM; Ingvorsen C; Thysen AH; Brix S
    Immunology; 2015 Feb; 144(2):333-42. PubMed ID: 25179236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures.
    Ghosh A; Saha S
    J Med Microbiol; 2022 Dec; 72(12):. PubMed ID: 36748565
    [No Abstract]   [Full Text] [Related]  

  • 5. The Lung Microbiome and Airway Disease.
    Lynch SV
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 2(Suppl 5):S462-S465. PubMed ID: 28005424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.
    Caverly LJ; LiPuma JJ
    Expert Rev Respir Med; 2018 Oct; 12(10):857-865. PubMed ID: 30118374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.
    Mendez R; Banerjee S; Bhattacharya SK; Banerjee S
    IUBMB Life; 2019 Feb; 71(2):152-165. PubMed ID: 30466159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
    Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
    J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The lung microbiome in 2015: a window on chronic lung diseases].
    Andréjak C; Delhaes L
    Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the bacterial microbiome in lung disease.
    Dickson RP; Erb-Downward JR; Huffnagle GB
    Expert Rev Respir Med; 2013 Jun; 7(3):245-57. PubMed ID: 23734647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Human Respiratory Microbiome: Current Understandings and Future Directions.
    Zhao L; Luo JL; Ali MK; Spiekerkoetter E; Nicolls MR
    Am J Respir Cell Mol Biol; 2023 Mar; 68(3):245-255. PubMed ID: 36476129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis.
    Boutin S; Depner M; Stahl M; Graeber SY; Dittrich SA; Legatzki A; von Mutius E; Mall M; Dalpke AH
    Mediators Inflamm; 2017; 2017():5047403. PubMed ID: 29445257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-microbe interactions in distal airways: relevance to chronic airway diseases.
    Martin C; Burgel PR; Lepage P; Andréjak C; de Blic J; Bourdin A; Brouard J; Chanez P; Dalphin JC; Deslée G; Deschildre A; Gosset P; Touqui L; Dusser D
    Eur Respir Rev; 2015 Mar; 24(135):78-91. PubMed ID: 25726559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral-lung microbiome interactions in lung diseases.
    Mammen MJ; Scannapieco FA; Sethi S
    Periodontol 2000; 2020 Jun; 83(1):234-241. PubMed ID: 32385873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications.
    Huang YJ; Lynch SV
    Expert Rev Respir Med; 2011 Dec; 5(6):809-21. PubMed ID: 22082166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lung microbiome in health and disease.
    Moffatt MF; Cookson WO
    Clin Med (Lond); 2017 Dec; 17(6):525-529. PubMed ID: 29196353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease.
    Park H; Shin JW; Park SG; Kim W
    PLoS One; 2014; 9(10):e109710. PubMed ID: 25329665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic diversity and antimicrobial resistance of
    Webb KA; Olagoke O; Baird T; Neill J; Pham A; Wells TJ; Ramsay KA; Bell SC; Sarovich DS; Price EP
    Microb Genom; 2022 Feb; 8(2):. PubMed ID: 35113778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Respiratory Flora in the Pathogenesis of Chronic Respiratory Diseases.
    Guo MY; Chen HK; Ying HZ; Qiu FS; Wu JQ
    Biomed Res Int; 2021; 2021():6431862. PubMed ID: 34435047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.